GSK’s long-acting injection beats Truvada in HIV prevention trial Reuters May 18, 2020 Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic EP News Bureau Oct 4, 2019 Descovy, the drug, is not indicated in individuals at risk of HIV-1 infection from receptive vaginal sex because the effectivness…
